SOX9 and breast cancer: The DNA methyltransferase inhibitor (DNMTi) 5-azacytidine (AZA) treated the BC cell line, and the J82 methylated cell line restored the expression of SOX9 at the transcriptional level compared with the RT4 unmethylated cell line (27).